Coalition for Epidemic Preparedness Innovations

- Vaxxinity Receives $9.25M Funding From CEPI To Support Pivotal COVID-19 Vaccine Trial
  Benzinga via Yahoo Finance· 1 year ago
  The Coalition for Epidemic Preparedness Innovations (CEPI) and Vaxxinity Inc (NASDAQ: VAXX) will...
- Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious...
  Benzinga via Yahoo Finance· 10 months ago
  Inovio Pharmaceuticals Inc (NASDAQ: INO) has agreed with its collaborator, the Coalition for...
- Gates, Wellcome pledge $150 million each to pandemic preparedness group
  Reuters via Yahoo News· 2 years ago
  Global health charities the Bill & Melinda Gates Foundation and Wellcome Trust each pledged $150...
- Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate
  Zacks via Yahoo Finance· 1 year ago
  Emergent BioSolutions EBS announced the dosing of the first patient in a phase I study evaluating...
- UK pledges £160m to help accelerate vaccine development
  Press Association News via AOL· 2 years ago
  The UK is pledging £160 million to a major scientific project working on speeding up vaccine...
- UK vaccine to protect against future pandemics gets backing
  Press Association News via AOL· 2 years ago
  Prime Minister Boris Johnson, who opened a conference hosted by the Coalition for Epidemic...
- COVID-19 vaccine scheme for poorest has $2.6bn left to spend as pandemic recedes
  Reuters via Yahoo News· 3 months ago
  Several billions of dollars left in a scheme to deliver COVID-19 vaccines to the world’s poorest...
- BioNTech wins up to $90 million in funding for mpox vaccine development
  Reuters via Yahoo News· 2 weeks ago
  BioNTech would initiate an early-to-mid stage trial for the vaccine program BNT166 to prevent mpox,...
- British agencies win CEPI funds to develop standard monkeypox tools
  Reuters via Yahoo News· 1 year ago
  LONDON (Reuters) -British health agencies have secured funding to develop a standardised approach to...
- Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
  Benzinga via Yahoo Finance· 2 years ago
  Valneva SE (NASDAQ: VALN) has initiated a Phase 3 trial in adolescents for its single-shot...